mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.08 |
mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.08 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.08 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.08 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.08 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.08 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.09 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.09 |
mRNA |
rTRAIL |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.09 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.09 |